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Nitric oxide, as well as being a major regulator of vascular reactivity, has been shown to be one of the medtators of cytotoxtcity in macrophages. 
This cytotoxic effect seems to be due to the interaction between nitric oxide and oxygen-related free radicals. This study shows that, m vitro. nitric 
oxide reacts with hydrogen peroxide to release large amounts of chemiluminescence with the characteristics of the highly cytotoxic species, singlet 
oxygen. This is supported by the observation that when mtric oxide was added to a superoxide generating system, catalase inhibited the production 
of singlet oxygen while superoxide dtsmutase enhanced It. 
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1. INTRODUCTION 2. EXPERIMENTAL 
Nitric oxide (NO) is the major determinant of vascu- 
lar tone [1,2]. It is constitutively produced by endothe- 
lial cells, catalysed by the calcium-dependent enzyme, 
NO synthase. In many cells there is also an inducible 
enzyme for NO production which is calcium independ- 
ent [3]. NO production via the inducible pathway has 
been shown to be one of the mediators of cytotoxicity 
in macrophages activated by microorganisms in vivo or 
by cytokinins in vitro [4-61. 
It has been suggested that NO may exert its cytotoxic 
function directly through the inhibition of mitochon- 
drial respiration and inhibition of the citric acid cycle 
[7], or indirectly by reacting with superoxide. The latter 
view is supported by Beckman et al. [8] who have sug- 
gested that the mechanism for such cytotoxicity might 
be the production of peroxynitrite from the reaction 
between superoxide and NO. Peroxynitrite decomposi- 
tion generates the hydroxyl radical, a strong oxidant. It 
was also hypothesized that this mechanism may play a 
role in ischemia-reperfusion i jury. 
We have studied the interactions between NO and 
superoxide, using chemiluminescence to identify the 
presence of oxygen-based free radicals, and, as a result 
wish to suggest an alternative: that NO reacts with hy- 
drogen peroxide to produce singlet oxygen, a highly 
reactive form of oxygen. 
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Saturated NO solutions were prepared by bubbling 20 ml of argon- 
deoxygenated water with NO gas (BDH). The solutions were kept at 
4°C and were stable for at least 3 h. Aliquots (200 ~1) of NO solution 
were injected, with a gas-tight syringe, directly into the samples while 
chemtlummescence was being measured. 
Chemtlummescence was measured in a luminometer designed by 
A.A. Dutra. whtch incorporates a gallium arsenide photomultiplier 
tube with a response above 10% of quantum efficiency in the wave- 
length range 200-900 nm. The samples tested (1 ml in 35 mm petri 
dishes covered with clingfilm) were kept at 37°C in a light-tight rotat- 
ing chamber above the photomultiplier tube. This chamber was deox- 
ygenated by purgmg wrth argon throughout the experiments. The 
selection of wavelengths was achieved by placing bandpass interfer- 
ence filters (Ealing Electra-Optics) in the chamber over the photomul- 
tiplier tube. 
All sample solutions were in 100 mM potassium phosphate buffer 
(pH 7.0-7.4). The samples of hydrogen peroxide (10 mM) and potas- 
sium superoxide (1 mM from a stock in crown ether (Aldrich, UK) 
dissolved in deoxygenated DMSO or acetonitrile) were made up in 
buffer deoxygenated with argon. Superoxide dismutase (2.5 U/ml) and 
catalase (10 U/ml) were added to a 0.1 U/ml xanthine oxidase/l mM 
hypoxanthine solution in 100 mM phosphate buffer (pH 7.2) before 
the mjectton of the NO-saturated solution. 
All chemicals were from Sigma (UK) unless otherwise stated. The 
experiments were repeated at least three times and the results are 
expressed as average counts/s. 
3. RESULTS AND DISCUSSION 
In our studies superoxide was produced either from 
potassium superoxide in crown ether, or from a xan- 
thine oxidaselhypoxanthine system. When a deoxygen- 
ated solution of NO was added to either of these super- 
oxide generating systems, a sharp increase in chemilu- 
minescence was observed at a wavelength compatible 
with that of singlet oxygen (Fig. la). In the course of 
these experiments we noted that the longer the interval 
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Fig. 1. (a) Chemtluminescence resultmg from the addttion of NO to hydrogen peroxide (v). potassmm superoxide in crown ether (a), or 
hypoxanthinekanthme oxidase (w). (b) The effect of superoxide dtsmutase (v) and catalase (v) on the chemiluminescence produced by the addmon 
of NO to a solutton of xanthme oxtdase/hypoxanthine. 
allowed to elapse before adding NO to the system, the 
greater the amount of chemiluminescence produced. At 
physiological pH (7.0-7.4) superoxide is very rapidly 
dismutated to hydrogen peroxide (K, = 5 x lo5 
M-’ . s-l) and this led us to investigate the possibility 
that the chemiluminescence we had observed was due 
to the interaction of NO with hydrogen peroxide. 
The addition of catalase to the xanthine oxidase/hy- 
poxanthine system before adding NO was followed by 
marked inhibition of light emission while the addition 
of superoxide dismutase was associated with an increase 
in light emission (Fig, 1 b). The addition of albumin (as 
a protein control) at the same molar concentration as 
the enzymes used had no effect on light emission. These 
results lend support to the suggestion that it is hydrogen 
peroxide rather than superoxide which reacts with the 
NO in this system. 
The following experiments confirmed that the chemi- 
luminescence we detected was due to singlet oxygen 
formation. 
(i) NO injected into a deoxygenated solution of hy- 
drogen peroxide in buffer produced chemiluminescence 
at wavelengths of 633 and 703 nm but not at 670 nm 
(Fig. 2). This is the region where the luminescence of 
dimol collision, characteristic of singlet oxygen, would 
be expected [9]. The same was true when the organic 
peroxides, butyl hydroperoxide and cumene hydroper- 
oxide, were used instead of hydrogen peroxide (data not 
shown). Neither hydrogen peroxide nor NO by them- 
selves showed chemiluminescence. 
(ii) In experiments using sodium nitroprusside as the 
source of NO, much more chemiluminescence was ob- 
served after the addition of hydrogen peroxide. when 
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enhancers of the chemiluminescence associated with 
singlet oxygen were used. When Smethoxy-vinylpyrene 
was added before the addition of hydrogen peroxide, 
there was an increase in chemiluminescence of the order 
of at least 1,000 times (200,000 cps compared with 200 
cps). This degree of enhancement was at least loo-times 
greater than that which occurred when another en- 
hancer, 7-8 bi-pyridine-dihydrodiol was used (2,000 
cps) (Fig. 3). This is consistent with the results obtained 
by Posner et al. [lo] using the same chemiluminescent 
probes for singlet oxygen. 
(iii) Further to confirm the involvement of singlet 
oxygen in the chemiluminescence resulting from the re- 
action between NO and hydrogen peroxide, we used the 
well-known quenchers of singlet oxygen, histidine and 
sodium azide, and found that they caused a decrease in 
the amount of chemiluminescence produced (Table I). 
Also, when deuterium oxide was used in making up the 
Table I 
The effect of varrous compounds on the chemiluminescence produced 
by the reaction between NO and hydrogen peroxide 
Treatment Chemtlummescence (cps) 
Control 1.398 + 1 I .2 
Histrdine (10 mM) 775 ? 9.8 
Sodium aztde (IO mM) 760 + 9.1 
Manmtol (1 mM) 1.369 ir 7.8 
DMSO (10%) 1,401 + 9.1 
Desferal (1 mM) 1.392 rt 7.6 
Results are expressed as average counts per second (cps) (recorded 
over pertods of 100 s) + SD 
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buffer, the degree of chemiluminescence was increased. 
This is consistent with the known effect of deuterium 
oxide in increasing the chemiluminescence due to the 
presence of singlet oxygen [l 11. 
The possibility that the chemiluminescence was due 
to the presence of free hydroxyl radicals was eliminated 
by using dimethyl sulphoxide at a concentration of 10% 
in the buffer or mannitol at a concentration of 1 mmo- 
lar. Both of these quench chemiluminescence due to free 
hydroxyl production, but no such effect was obtained 
when either of these compounds were added to the sys- 
tems described above. Similarly, desferal, an inhibitor 
of iron-dependent free hydroxyl formation, did not in- 
hibit chemiluminescence when NO was added to a hy- 
drogen peroxide solution in buffer (Table I). 
Recently Murphy and Sies [12] have suggested that 
superoxide dismutase could effect the process by which 
NO- (which could be formed by NO-synthesizing en- 
zymes) is converted to NO. In our experiments using 
superoxide-generating systems and NO-purged water, 
superoxide dismutase increased light emission by about 
50%, however, it had no effect in the experiments in 
which hydrogen peroxide was used instead of a superox- 
ide-generating system. This suggests that in this case, 
superoxide dismutase is acting only on superoxide, lead- 
ing to its faster dismutation to hydrogen peroxide. 
We have thus shown that NO can react with hydro- 
gen peroxide, giving rise to singlet oxygen, a highly 
reactive oxygen species. In conditions of cell injury or 
inflammation, not only NO is produced, but also a large 
amount of superoxide dismutase (present in abundance 
in all human tissue) is released leading to a quick dismu- 
tation of superoxide to hydrogen peroxide. Therefore, 
Fig. 2. Chemilummescence produced durmg the reaction of NO with 
hydrogen peroxide measured through interference filters at 703 nm 
(v), 633 nm (0). and 670 nm (m) 
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Fig. 3. The effect of smglet oxygen enhancers on the chemilumines- 
cence produced after the addttion of hydrogen peroxide to a sodium 
mtroprusside solution Bars show the maximum chemilummescence 
produced after the injection of 10 mM hydrogen peroxide to 1 mM 
sodium nitroprusside in 10 mM potassium phosphate buffer, pH 7.2, 
(200 cps), and the effect of addmg 13 nM 7.8 bipyridine-dthydrodiol 
(7.8 dtol) (2,000 cps) or 13 nM 5-trans-methoxy vinylpyrene (T-MVP) 
(a 200,000 cps) to the same system. The enhancers were kept in stock 
solutions m methanol and were added to 1 ml samples of sodium 
mtroprusside before the addttton of hydrogen peroxtde. 
at any given time the concentration of hydrogen perox- 
ide in the tissue is likely to be much higher than that of 
superoxide, favouring the reaction described above. 
The idea that the reaction above may be involved in the 
cytotoxicity of macrophages is supported by the find- 
ings of Li et al. [ 131, showing that the killing of Leishmn- 
niu by macrophages, known to be mediated by NO, is 
inhibited by catalase, and is thus dependent on the pres- 
ence of hydrogen peroxide. 
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